Search PubMedSearch

PubMed · 41181421

The chicken chorioallantoic membrane model for human surgeries and implants.

Abstract

The fertilized chick egg, particularly its chorioallantoic membrane (CAM), has emerged as a valuable model in biomedical research due to its extensive applications in vascular studies, cancer investigations, surgical advancements including neurological, gynecological, urological, and retinal procedures, drug evaluation, and implant assessments. This review provides an in-depth examination of the chicken genome, structural composition of CAM, developmental progression, vascularization patterns, and cellular regulatory mechanisms. Furthermore, it underscores the CAM's significance in assessing therapeutic kinetics, biocompatibility, biodistribution, and drug effectiveness. A particular focus is placed on its role in analyzing vascular-disrupting agents (VDAs) for cancer treatment, alongside the incorporation of advanced imaging technologies such as photodynamic therapy, radiotherapy, positron emission tomography (PET)/computed tomography (CT) imaging, ultrasound techniques, and AI-driven detection methods for real-time vascular monitoring. By evaluating its advantages, limitations, and applications, this study establishes that CAM is a crucial alternative model for biomedical research, facilitating enhanced experimental design and methodological refinement.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Somya Rajput, Pooja Pandey, Trisha Gaur, Rekha Khandia, Pankaj Gurjar. 2025-07-14. The chicken chorioallantoic membrane model for human surgeries and implants.. https://doi.org/10.1097/ms9.0000000000003555

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Shared ligand-blocking mechanism but distinct conformational modulation by α5-targeting antibodies BIIG2 and MINT1526A.

Integrins are heterodimeric receptors important for cell adhesion and signaling. Integrin α5β1 is a key mediator of angiogenesis and its dysregulation is associated with tumor progression and metastasis. Despite numerous efforts, α5β1-targeting therapeutics have been unsuccessful due to poor efficacy and off-target effects. A contributing factor is our limited understanding of how integrin conformation influences interactions with therapeutics. Using cell-based functional assays, patient-derived xenografts, biophysics, X-ray crystallography, and electron microscopy, we shed light on these relationships by characterizing two anti-α5β1 antibodies, BIIG2 and MINT1526A. We show that both antibodies bind α5β1 with nanomolar affinity, reduce tube formation in vitro, and bind overlapping epitopes that block fibronectin binding. However, using electron microscopy, we reveal that while BIIG2 binding does not substantially alter the conformational states, MINT1526A preferentially recognizes the bent conformation and restricts the conformational ensemble. These insights can guide which aspects to prioritize to improve the design of future integrin-targeted therapeutics.

angiogenesis